Ainos (AIMDW) Stock Analysis

What Ainos does

Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit. This is complemented by the Ainos' cloud-based test management App, a holistic platform comprising the rapid test kit, a personal mobile application, and an enterprise-level app. Ainos also provides a COVID-19 nucleic acid test. Further technologies under development or offered include point-of-care testing for volatile organic compounds and Very Low-Dose Oral Interferon Alpha, an oral formulation of IFN-a with broad therapeutic potential. The firm is additionally developing a Synthetic RNA (SRNA) technology platform, with specific work being conducted in Taiwan. Beyond these, Ainos' product line extends to women's health, pneumonia, the Ainos Pen, AI Nose, and a variety of other products. Originally incorporated in 1984, the company was formerly known as Amarillo Biosciences, Inc. and rebranded to Ainos, Inc. in May 2021. Its main operations are based in San Diego, California.

Key metrics

ETFs linked to AIMDW

Broad-market and Healthcare sector ETFs an investor holding Ainos is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AIMDW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Ainos?

Ainos trades under the ticker AIMDW on NASDAQ.

Which exchange is AIMDW listed on?

AIMDW is listed on NASDAQ.

What sector does Ainos operate in?

Ainos is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AIMDW in a portfolio?

PortView shows AIMDW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.